Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessCompaniesDr Reddy's gets US nod for osteoporosis drug

    Dr Reddy's gets US nod for osteoporosis drug

    Dr Reddy's Laboratories has received US Food and Drug Administration's approval for selling ibandronate sodium tablets used to treat osteoporosis, the regulator's website showed on Thursday.

    May 03, 2012 / 16:30 IST

    Dr Reddy's Laboratories has received US Food and Drug Administration's approval for selling ibandronate sodium tablets used to treat osteoporosis, the regulator's website showed on Thursday.


    The tablets are the generic version of Boniva, a brand sold by a unit of Swiss drugmaker Roche.

    Cipla, another Indian drugmaker, received US regulatory approval for AIDS treatment drug nevirapine, the website showed. The drug is a generic version of German drugmaker Boehringer Ingelheim's Viramune tablets.

    first published: May 3, 2012 03:26 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347